Specialty Pharmacy

National Pharmacist Day, celebrated annually on January 12, honors pharmacists across different specialties and in every setting by recognizing the impact they have in health care.

Study shows the United States spends more on health care on a per capita basis than other developed countries, mostly due to higher prices.

High consumption of sugary beverages has previously been linked to obesity, diabetes, and some types of cancer.

Top news of the day across the health care landscape.

Patients with hepatitis C virus treated with direct acting antiviral drugs showed successful long-term outcomes regardless of receiving opioid substitution therapy for drug addiction.

The world is rapidly moving towards the adoption and seamless integration of artificial intelligence (AI), including machine learning as a subset of AI, throughout our daily lives.

A survey of California 2017 enrollees estimates how drops in enrollment may affect premium increases.

Top news of the day across the health care landscape.

Combination of glecaprevir and pibrentasvir for hepatitis C virus genotype 3 effective over an 8-week treatment duration.

Involvement with the organizations and nonprofit foundations that focus on specialty disease states can help specialty pharmacists gain perspective on the patients they treat.

Crizanlizumab (SEG101, Novartis) is being developed to prevent painful complications called vaso-occlusive crises in patients with sickle cell disease.

Study suggests a new therapy could stop tumor growth by affecting myeloid cell behavior.

Top news of the day across the health care landscape.

Community-acquired pneumonia is a major cause of mortality and morbidity among patients with HIV.

A multimethod approach including use of refill data may be the most effective method to identify nonadherence in young patients with chronic kidney disease.

Controlling the viral reaction of cells latently infected with HIV may have implications for future drug treatments.

Doris Quon, MD, Medical Director at the Orthopaedic Hemophilia Treatment Center, discusses the main takeaways from phase 3 HAVEN trial data for emicizumab (Hemlibra) prophylaxis in hemophilia.

Top news of the day across the health care landscape.

A substantial portion of mortality from liver cirrhosis and hepatocellular carcinoma can be attributed to the extrahepatic manifestations associated with hepatitis C virus.

Advancements in targeted therapies have helped significantly improve survival in late-stage anaplastic lymphoma kinase positive non-small cell lung cancer.

Top news of the day across the health care landscape.

Making the patients’ lives easier is at the heart of my job.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

Study finds that treating hepatitis C reduced the risk of developing the signs and symptoms of Parkinson disease.

New high-cost gene therapies are pushing health care providers to explore new methods to help the US health care system to fund specialty drugs.

Top news of the day across the health care landscape.

Researches seeking to eliminate HIV are close enough to see the finish line, but with no idea how far away they are from a cure.

Transcranial direct current stimulation shows promise in addressing fatigue in patients with multiple sclerosis.

The FDA has approved dasatinib (Sprycel) tablets in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.